speb/financial-data huggingface dataset:
ICU income_statement (annual, 2025-12-31) — Basic EPS: -5.86
ICU income_statement (quarterly, 2025-12-31) — Basic EPS: -0.80
ICU cash_flow (annual, 2025-12-31) — Beginning Cash Position: 1819000.00
ICU cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 13763000.00
ICU balance_sheet (annual, 2025-12-31) — Capital Stock: 4000.00
ICU balance_sheet (quarterly, 2025-12-31) — Capital Stock: 4000.00
ICU balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 11980000.00
ICU balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 11980000.00
ICU balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 11980000.00
ICU balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 11980000.00
ICU balance_sheet (annual, 2025-12-31) — Cash Financial: 11980000.00
ICU balance_sheet (quarterly, 2025-12-31) — Cash Financial: 11980000.00
ICU cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 23760000.00
ICU cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 2311000.00
ICU cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -13599000.00
ICU cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -4094000.00
ICU cash_flow (annual, 2025-12-31) — Change In Account Payable: -2098000.00
ICU cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -1070000.00
ICU cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -920000.00
ICU cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 221000.00
ICU cash_flow (annual, 2025-12-31) — Change In Inventory: -66000.00
ICU cash_flow (quarterly, 2025-12-31) — Change In Inventory: 17000.00
ICU cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 314000.00
ICU cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 78000.00
ICU cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 0.00
ICU cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 0.00
ICU cash_flow (annual, 2025-12-31) — Change In Payable: -2098000.00
ICU cash_flow (quarterly, 2025-12-31) — Change In Payable: -1070000.00
ICU cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -3018000.00
ICU cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -849000.00
ICU cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 538000.00
ICU cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -490000.00
ICU cash_flow (annual, 2025-12-31) — Change In Receivables: -125000.00
ICU cash_flow (quarterly, 2025-12-31) — Change In Receivables: -16000.00
ICU cash_flow (annual, 2025-12-31) — Change In Working Capital: -2357000.00
ICU cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -1260000.00
ICU cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -125000.00
ICU cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -16000.00
ICU cash_flow (annual, 2025-12-31) — Changes In Cash: 10161000.00
ICU cash_flow (quarterly, 2025-12-31) — Changes In Cash: -1783000.00
ICU balance_sheet (annual, 2025-12-31) — Common Stock: 4000.00
ICU balance_sheet (quarterly, 2025-12-31) — Common Stock: 4000.00
ICU balance_sheet (annual, 2025-12-31) — Common Stock Equity: 10416000.00
ICU balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 10416000.00
ICU cash_flow (annual, 2025-12-31) — Common Stock Issuance: 16126000.00
ICU cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 1789000.00
ICU income_statement (annual, 2025-12-31) — Cost Of Revenue: 53000.00
ICU income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 12000.00
ICU balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 2268000.00
ICU balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 2268000.00
ICU balance_sheet (annual, 2025-12-31) — Current Assets: 13580000.00
ICU balance_sheet (quarterly, 2025-12-31) — Current Assets: 13580000.00
ICU balance_sheet (annual, 2025-12-31) — Current Debt: 525000.00
ICU balance_sheet (quarterly, 2025-12-31) — Current Debt: 525000.00
ICU balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 525000.00
ICU balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 525000.00
ICU balance_sheet (annual, 2025-12-31) — Current Liabilities: 3742000.00
ICU balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 3742000.00
ICU income_statement (annual, 2025-12-31) — Diluted Average Shares: 2073087.00
ICU income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 3621696.00
ICU income_statement (annual, 2025-12-31) — Diluted EPS: -5.86
ICU income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.80
ICU income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -12150000.00
ICU income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -2904000.00
ICU income_statement (annual, 2025-12-31) — EBIT: -12116000.00
ICU income_statement (quarterly, 2025-12-31) — EBIT: -2891000.00
ICU income_statement (annual, 2025-12-31) — EBITDA: -12116000.00
ICU income_statement (quarterly, 2025-12-31) — EBITDA: -2891000.00
ICU cash_flow (annual, 2025-12-31) — End Cash Position: 11980000.00
ICU cash_flow (quarterly, 2025-12-31) — End Cash Position: 11980000.00
ICU cash_flow (annual, 2025-12-31) — Financing Cash Flow: 23760000.00
ICU cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 2311000.00
ICU cash_flow (annual, 2025-12-31) — Free Cash Flow: -13599000.00
ICU cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -4094000.00
ICU cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -32000.00
ICU cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 0.00
ICU income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 32000.00
ICU income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 0.00
ICU income_statement (annual, 2025-12-31) — General And Administrative Expense: 5838000.00
ICU income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 1224000.00
ICU balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 240000.00
ICU balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 240000.00
ICU income_statement (annual, 2025-12-31) — Gross Profit: 1181000.00
ICU income_statement (quarterly, 2025-12-31) — Gross Profit: 408000.00
ICU cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 3000.00
ICU income_statement (annual, 2025-12-31) — Interest Expense: 31000.00
ICU income_statement (quarterly, 2025-12-31) — Interest Expense: 13000.00
ICU income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 31000.00
ICU income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 13000.00
ICU income_statement (annual, 2025-12-31) — Interest Income: 325000.00
ICU income_statement (quarterly, 2025-12-31) — Interest Income: 125000.00
ICU income_statement (annual, 2025-12-31) — Interest Income Non Operating: 325000.00
ICU income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 125000.00
ICU cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 0.00
ICU cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 0.00
ICU balance_sheet (annual, 2025-12-31) — Inventory: 66000.00
ICU balance_sheet (quarterly, 2025-12-31) — Inventory: 66000.00
ICU balance_sheet (annual, 2025-12-31) — Invested Capital: 10941000.00
ICU balance_sheet (quarterly, 2025-12-31) — Invested Capital: 10941000.00
ICU cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 16126000.00
ICU cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 1789000.00
ICU cash_flow (annual, 2025-12-31) — Issuance Of Debt: 767000.00
ICU cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 767000.00
ICU cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 767000.00
ICU cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -834000.00
ICU cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 16126000.00
ICU cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 1789000.00
ICU income_statement (annual, 2025-12-31) — Net Income: -12150000.00
ICU income_statement (quarterly, 2025-12-31) — Net Income: -2904000.00
ICU income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -12150000.00
ICU income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -2904000.00
ICU income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -12150000.00
ICU income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -2904000.00
ICU income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -12150000.00
ICU income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -2904000.00
ICU income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -12150000.00
ICU income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -2904000.00
ICU cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -12150000.00
ICU cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -2904000.00
ICU income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -12150000.00
ICU income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -2904000.00
ICU income_statement (annual, 2025-12-31) — Net Interest Income: -4000.00
ICU income_statement (quarterly, 2025-12-31) — Net Interest Income: 112000.00
ICU cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -67000.00
ICU cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 525000.00
ICU cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -67000.00
ICU income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -4000.00
ICU income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 112000.00
ICU balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 10416000.00
ICU balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 10416000.00
ICU income_statement (annual, 2025-12-31) — Normalized EBITDA: -12148000.00
ICU income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -2891000.00
ICU income_statement (annual, 2025-12-31) — Normalized Income: -12175280.00
ICU income_statement (quarterly, 2025-12-31) — Normalized Income: -2904000.00
ICU cash_flow (annual, 2025-12-31) — Operating Cash Flow: -13599000.00
ICU cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -4094000.00
ICU cash_flow (annual, 2025-12-31) — Operating Gains Losses: -32000.00
ICU cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 0.00
ICU income_statement (annual, 2025-12-31) — Operating Income: -12175000.00
ICU income_statement (quarterly, 2025-12-31) — Operating Income: -3016000.00
ICU income_statement (annual, 2025-12-31) — Operating Revenue: 1234000.00
ICU income_statement (quarterly, 2025-12-31) — Operating Revenue: 420000.00
ICU balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 3844613.00
ICU balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 3844613.00
ICU balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 525000.00
ICU balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 525000.00
ICU balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 1000.00
ICU balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 1000.00
ICU income_statement (annual, 2025-12-31) — Other Gand A: 5838000.00
ICU income_statement (quarterly, 2025-12-31) — Other Gand A: 1224000.00
ICU income_statement (annual, 2025-12-31) — Other Income Expense: 32000.00
ICU income_statement (quarterly, 2025-12-31) — Other Income Expense: 0.00
ICU cash_flow (annual, 2025-12-31) — Other Non Cash Items: 316000.00
ICU cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 0.00
ICU balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 578000.00
ICU balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 578000.00
ICU balance_sheet (annual, 2025-12-31) — Payables: 948000.00
ICU balance_sheet (quarterly, 2025-12-31) — Payables: 948000.00
ICU balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 3216000.00
ICU balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 3216000.00
ICU balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
ICU balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
ICU balance_sheet (annual, 2025-12-31) — Prepaid Assets: 1297000.00
ICU balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 1297000.00
ICU income_statement (annual, 2025-12-31) — Pretax Income: -12147000.00
ICU income_statement (quarterly, 2025-12-31) — Pretax Income: -2904000.00
ICU cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 7701000.00
ICU cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: -3000.00
ICU balance_sheet (annual, 2025-12-31) — Receivables: 237000.00
ICU balance_sheet (quarterly, 2025-12-31) — Receivables: 237000.00
ICU income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 53000.00
ICU income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 12000.00
ICU cash_flow (annual, 2025-12-31) — Repayment Of Debt: -834000.00
ICU cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -242000.00
ICU income_statement (annual, 2025-12-31) — Research And Development: 7518000.00
ICU income_statement (quarterly, 2025-12-31) — Research And Development: 2200000.00
ICU balance_sheet (annual, 2025-12-31) — Retained Earnings: -151714000.00
ICU balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -151714000.00
ICU income_statement (annual, 2025-12-31) — Selling General And Administration: 5838000.00
ICU income_statement (quarterly, 2025-12-31) — Selling General And Administration: 1224000.00
ICU balance_sheet (annual, 2025-12-31) — Share Issued: 3844613.00
ICU balance_sheet (quarterly, 2025-12-31) — Share Issued: 3844613.00
ICU cash_flow (annual, 2025-12-31) — Stock Based Compensation: 624000.00
ICU cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 70000.00
ICU balance_sheet (annual, 2025-12-31) — Stockholders Equity: 10416000.00
ICU balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 10416000.00
ICU balance_sheet (annual, 2025-12-31) — Tangible Book Value: 10416000.00
ICU balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 10416000.00
ICU income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 6720.00
ICU income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ICU income_statement (annual, 2025-12-31) — Tax Provision: 3000.00
ICU income_statement (quarterly, 2025-12-31) — Tax Provision: 0.00
ICU income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
ICU income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
ICU balance_sheet (annual, 2025-12-31) — Total Assets: 14158000.00
ICU balance_sheet (quarterly, 2025-12-31) — Total Assets: 14158000.00
ICU balance_sheet (annual, 2025-12-31) — Total Capitalization: 10416000.00
ICU balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 10416000.00
ICU balance_sheet (annual, 2025-12-31) — Total Debt: 525000.00
ICU balance_sheet (quarterly, 2025-12-31) — Total Debt: 525000.00
ICU balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 10416000.00
ICU balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 10416000.00
ICU income_statement (annual, 2025-12-31) — Total Expenses: 13409000.00
ICU income_statement (quarterly, 2025-12-31) — Total Expenses: 3436000.00
ICU balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 3742000.00
ICU balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 3742000.00
ICU balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 578000.00
ICU balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 578000.00
ICU balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
ICU balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
ICU income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -12175000.00
ICU income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -3016000.00
ICU income_statement (annual, 2025-12-31) — Total Other Finance Cost: 298000.00
ICU income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 0.00
ICU income_statement (annual, 2025-12-31) — Total Unusual Items: 32000.00
ICU income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
ICU income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 32000.00
ICU income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
ICU cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
ICU cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
ICU balance_sheet (annual, 2025-12-31) — Working Capital: 9838000.00
ICU balance_sheet (quarterly, 2025-12-31) — Working Capital: 9838000.00
ICU income_statement (quarterly, 2026-03-31) — +Operating Expense: 4052000.00
ICU income_statement (quarterly, 2026-03-31) — +Total Revenue: 495000.00
ICU balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 719000.00
ICU balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 179000.00
ICU balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 162546000.00
ICU balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -1000.00
ICU income_statement (quarterly, 2026-03-31) — Basic Average Shares: 3918339.00
ICU income_statement (quarterly, 2026-03-31) — Basic EPS: -0.90
ICU cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 11980000.00
ICU balance_sheet (quarterly, 2026-03-31) — Capital Stock: 4000.00
ICU balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 9348000.00
ICU balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 9348000.00
ICU balance_sheet (quarterly, 2026-03-31) — Cash Financial: 9348000.00
ICU cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 129000.00
ICU cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -2761000.00
ICU cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -229000.00
ICU cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 629000.00
ICU cash_flow (quarterly, 2026-03-31) — Change In Inventory: 9000.00
ICU cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 79000.00
ICU cash_flow (quarterly, 2026-03-31) — Change In Payable: -229000.00
ICU cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 400000.00
ICU cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 117000.00
ICU cash_flow (quarterly, 2026-03-31) — Change In Receivables: 58000.00
ICU cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 663000.00
ICU cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 58000.00
ICU cash_flow (quarterly, 2026-03-31) — Changes In Cash: -2632000.00
ICU balance_sheet (quarterly, 2026-03-31) — Common Stock: 4000.00
ICU balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 7315000.00
ICU cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 329000.00
ICU income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 46000.00
ICU balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 2897000.00
ICU balance_sheet (quarterly, 2026-03-31) — Current Assets: 10764000.00
ICU balance_sheet (quarterly, 2026-03-31) — Current Debt: 331000.00
ICU balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 331000.00
ICU balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 3948000.00
ICU balance_sheet (quarterly, 2026-03-31) — Current Notes Payable: 331000.00
ICU income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 3918339.00
ICU income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.90
ICU income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -3521000.00
ICU income_statement (quarterly, 2026-03-31) — EBIT: -3512000.00
ICU income_statement (quarterly, 2026-03-31) — EBITDA: -3512000.00
ICU cash_flow (quarterly, 2026-03-31) — End Cash Position: 9348000.00
ICU cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 129000.00
ICU cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -2761000.00
ICU income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 1708000.00
ICU balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 180000.00
ICU income_statement (quarterly, 2026-03-31) — Gross Profit: 449000.00
ICU income_statement (quarterly, 2026-03-31) — Interest Expense: 6000.00
ICU income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 6000.00
ICU income_statement (quarterly, 2026-03-31) — Interest Income: 91000.00
ICU income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 91000.00
ICU cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 0.00
ICU balance_sheet (quarterly, 2026-03-31) — Inventory: 57000.00
ICU balance_sheet (quarterly, 2026-03-31) — Invested Capital: 7646000.00
ICU cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 329000.00
ICU cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -200000.00
ICU cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 329000.00
ICU income_statement (quarterly, 2026-03-31) — Net Income: -3521000.00
ICU income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -3521000.00
ICU income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -3521000.00
ICU income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -3521000.00
ICU income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -3521000.00
ICU cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -3521000.00
ICU income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -3521000.00
ICU income_statement (quarterly, 2026-03-31) — Net Interest Income: 85000.00
ICU cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -200000.00
ICU cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -200000.00
ICU income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 85000.00
ICU balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 7315000.00
ICU income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -3512000.00
ICU income_statement (quarterly, 2026-03-31) — Normalized Income: -3521000.00
ICU cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -2761000.00
ICU income_statement (quarterly, 2026-03-31) — Operating Income: -3603000.00
ICU income_statement (quarterly, 2026-03-31) — Operating Revenue: 495000.00
ICU balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 3993719.00
ICU balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1000.00
ICU income_statement (quarterly, 2026-03-31) — Other Gand A: 1708000.00
ICU cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 6000.00
ICU balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 499000.00
ICU balance_sheet (quarterly, 2026-03-31) — Payables: 719000.00
ICU balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 3616000.00
ICU balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
ICU balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 1180000.00
ICU income_statement (quarterly, 2026-03-31) — Pretax Income: -3518000.00
ICU cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 0.00
ICU balance_sheet (quarterly, 2026-03-31) — Receivables: 179000.00
ICU income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 46000.00
ICU cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -200000.00
ICU income_statement (quarterly, 2026-03-31) — Research And Development: 2344000.00
ICU balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -155235000.00
ICU income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1708000.00
ICU balance_sheet (quarterly, 2026-03-31) — Share Issued: 3993719.00
ICU cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 91000.00
ICU balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 7315000.00
ICU balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 7315000.00
ICU income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
ICU income_statement (quarterly, 2026-03-31) — Tax Provision: 3000.00
ICU income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
ICU balance_sheet (quarterly, 2026-03-31) — Total Assets: 11263000.00
ICU balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 7315000.00
ICU balance_sheet (quarterly, 2026-03-31) — Total Debt: 331000.00
ICU balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 7315000.00
ICU income_statement (quarterly, 2026-03-31) — Total Expenses: 4098000.00
ICU balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 3948000.00
ICU balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 499000.00
ICU balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
ICU income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -3603000.00
ICU balance_sheet (quarterly, 2026-03-31) — Working Capital: 6816000.00
ICU.AX income_statement (annual, 2021-06-30) — +Total Revenue: 438434.00
ICU.AX balance_sheet (annual, 2021-06-30) — Accounts Payable: 665281.00
ICU.AX income_statement (annual, 2021-06-30) — Basic Average Shares: 81250370.00
ICU.AX income_statement (annual, 2021-06-30) — Basic EPS: -0.01
ICU.AX cash_flow (annual, 2021-06-30) — Beginning Cash Position: 59544.00
ICU.AX balance_sheet (annual, 2021-06-30) — Capital Stock: 27888293.00
ICU.AX balance_sheet (annual, 2021-06-30) — Cash And Cash Equivalents: 197230.00
ICU.AX balance_sheet (annual, 2021-06-30) — Cash Cash Equivalents And Federal Funds Sold: 197230.00
ICU.AX balance_sheet (annual, 2021-06-30) — Cash Cash Equivalents And Short Term Investments: 197230.00
ICU.AX balance_sheet (annual, 2021-06-30) — Cash Financial: 197230.00
ICU.AX cash_flow (annual, 2021-06-30) — Cash Flow From Continuing Financing Activities: 652040.00
ICU.AX cash_flow (annual, 2021-06-30) — Cash Flowsfromusedin Operating Activities Direct: -514354.00
ICU.AX cash_flow (annual, 2021-06-30) — Changes In Cash: 137686.00
ICU.AX cash_flow (annual, 2021-06-30) — Classesof Cash Payments: -2819244.00
ICU.AX cash_flow (annual, 2021-06-30) — Classesof Cash Receiptsfrom Operating Activities: 2304890.00
ICU.AX balance_sheet (annual, 2021-06-30) — Common Stock: 27888293.00
ICU.AX balance_sheet (annual, 2021-06-30) — Common Stock Equity: -2210214.00
ICU.AX balance_sheet (annual, 2021-06-30) — Current Debt: 297044.00
ICU.AX balance_sheet (annual, 2021-06-30) — Current Debt And Capital Lease Obligation: 297044.00
ICU.AX balance_sheet (annual, 2021-06-30) — Current Provisions: 99854.00
ICU.AX income_statement (annual, 2021-06-30) — Depreciation Amortization Depletion Income Statement: 278050.00
ICU.AX income_statement (annual, 2021-06-30) — Depreciation And Amortization In Income Statement: 278050.00
ICU.AX income_statement (annual, 2021-06-30) — Depreciation Income Statement: 278050.00
ICU.AX income_statement (annual, 2021-06-30) — Diluted Average Shares: 81250370.00
ICU.AX income_statement (annual, 2021-06-30) — Diluted EPS: -0.01
ICU.AX income_statement (annual, 2021-06-30) — EBIT: -973704.00
ICU.AX income_statement (annual, 2021-06-30) — EBITDA: -695654.00
ICU.AX cash_flow (annual, 2021-06-30) — End Cash Position: 197230.00
ICU.AX cash_flow (annual, 2021-06-30) — Financing Cash Flow: 652040.00
ICU.AX cash_flow (annual, 2021-06-30) — Free Cash Flow: -514354.00
ICU.AX income_statement (annual, 2021-06-30) — General And Administrative Expense: 1409999.00
ICU.AX balance_sheet (annual, 2021-06-30) — Gross PPE: 643948.00
ICU.AX income_statement (annual, 2021-06-30) — Impairment Of Capital Assets: 13500.00
ICU.AX income_statement (annual, 2021-06-30) — Interest Expense: 225765.00
ICU.AX income_statement (annual, 2021-06-30) — Interest Income: 253.00
ICU.AX balance_sheet (annual, 2021-06-30) — Invested Capital: 731011.00
ICU.AX cash_flow (annual, 2021-06-30) — Issuance Of Debt: 1000000.00
ICU.AX balance_sheet (annual, 2021-06-30) — Long Term Debt: 2644181.00
ICU.AX balance_sheet (annual, 2021-06-30) — Long Term Debt And Capital Lease Obligation: 2644181.00
ICU.AX cash_flow (annual, 2021-06-30) — Long Term Debt Issuance: 1000000.00
ICU.AX cash_flow (annual, 2021-06-30) — Long Term Debt Payments: -347960.00
ICU.AX balance_sheet (annual, 2021-06-30) — Long Term Equity Investment: 150000.00
ICU.AX balance_sheet (annual, 2021-06-30) — Machinery Furniture Equipment: 643948.00
ICU.AX balance_sheet (annual, 2021-06-30) — Net Debt: 2743995.00
ICU.AX income_statement (annual, 2021-06-30) — Net Income: -1199469.00
ICU.AX income_statement (annual, 2021-06-30) — Net Income Common Stockholders: -1199469.00
ICU.AX income_statement (annual, 2021-06-30) — Net Income Continuous Operations: -1199469.00
ICU.AX income_statement (annual, 2021-06-30) — Net Income From Continuing And Discontinued Operation: -1199469.00
ICU.AX income_statement (annual, 2021-06-30) — Net Income From Continuing Operation Net Minority Interest: -1199469.00
ICU.AX income_statement (annual, 2021-06-30) — Net Income Including Noncontrolling Interests: -1199469.00
ICU.AX income_statement (annual, 2021-06-30) — Net Interest Income: -225512.00
ICU.AX cash_flow (annual, 2021-06-30) — Net Issuance Payments Of Debt: 652040.00
ICU.AX cash_flow (annual, 2021-06-30) — Net Long Term Debt Issuance: 652040.00
ICU.AX balance_sheet (annual, 2021-06-30) — Net PPE: 643948.00
ICU.AX balance_sheet (annual, 2021-06-30) — Net Tangible Assets: -2210214.00
ICU.AX balance_sheet (annual, 2021-06-30) — Non Current Deferred Liabilities: 80988.00
ICU.AX balance_sheet (annual, 2021-06-30) — Non Current Deferred Taxes Liabilities: 80988.00
ICU.AX income_statement (annual, 2021-06-30) — Normalized EBITDA: -682154.00
ICU.AX income_statement (annual, 2021-06-30) — Normalized Income: -1185969.00
ICU.AX income_statement (annual, 2021-06-30) — Operating Revenue: 438434.00
ICU.AX balance_sheet (annual, 2021-06-30) — Ordinary Shares Number: 81250370.00
ICU.AX cash_flow (annual, 2021-06-30) — Other Cash Paymentsfrom Operating Activities: 122615.00
ICU.AX balance_sheet (annual, 2021-06-30) — Other Current Borrowings: 297044.00
ICU.AX income_statement (annual, 2021-06-30) — Other Gand A: 1071071.00
ICU.AX income_statement (annual, 2021-06-30) — Other Non Interest Expense: 44500.00
ICU.AX income_statement (annual, 2021-06-30) — Other Non Operating Income Expenses: 108146.00
ICU.AX balance_sheet (annual, 2021-06-30) — Other Receivables: 284854.00
ICU.AX balance_sheet (annual, 2021-06-30) — Payables: 665281.00
ICU.AX balance_sheet (annual, 2021-06-30) — Payables And Accrued Expenses: 665281.00
ICU.AX income_statement (annual, 2021-06-30) — Pretax Income: -1199469.00
ICU.AX balance_sheet (annual, 2021-06-30) — Receivables: 284854.00
ICU.AX income_statement (annual, 2021-06-30) — Reconciled Depreciation: 278050.00
ICU.AX cash_flow (annual, 2021-06-30) — Repayment Of Debt: -347960.00
ICU.AX balance_sheet (annual, 2021-06-30) — Retained Earnings: -30098507.00
ICU.AX income_statement (annual, 2021-06-30) — Salaries And Wages: 338928.00
ICU.AX income_statement (annual, 2021-06-30) — Selling General And Administration: 1409999.00
ICU.AX balance_sheet (annual, 2021-06-30) — Share Issued: 81250370.00
ICU.AX income_statement (annual, 2021-06-30) — Special Income Charges: -13500.00
ICU.AX balance_sheet (annual, 2021-06-30) — Stockholders Equity: -2210214.00
ICU.AX balance_sheet (annual, 2021-06-30) — Tangible Book Value: -2210214.00
ICU.AX income_statement (annual, 2021-06-30) — Tax Effect Of Unusual Items: 0.00
ICU.AX income_statement (annual, 2021-06-30) — Tax Provision: 0.00
ICU.AX income_statement (annual, 2021-06-30) — Tax Rate For Calcs: 0.00
ICU.AX balance_sheet (annual, 2021-06-30) — Total Assets: 1577134.00
ICU.AX balance_sheet (annual, 2021-06-30) — Total Capitalization: 433967.00
ICU.AX balance_sheet (annual, 2021-06-30) — Total Debt: 2941225.00
ICU.AX balance_sheet (annual, 2021-06-30) — Total Equity Gross Minority Interest: -2210214.00
ICU.AX balance_sheet (annual, 2021-06-30) — Total Liabilities Net Minority Interest: 3787348.00
ICU.AX income_statement (annual, 2021-06-30) — Total Unusual Items: -13500.00
ICU.AX income_statement (annual, 2021-06-30) — Total Unusual Items Excluding Goodwill: -13500.00
ICU.AX income_statement (annual, 2022-06-30) — +Total Revenue: -1225554.00
ICU.AX balance_sheet (annual, 2022-06-30) — Accounts Payable: 630089.00
ICU.AX balance_sheet (annual, 2022-06-30) — Accounts Receivable: 45088.00
ICU.AX balance_sheet (annual, 2022-06-30) — Allowance For Doubtful Accounts Receivable: -77000.00
ICU.AX income_statement (annual, 2022-06-30) — Basic Average Shares: 115431405.00
ICU.AX income_statement (annual, 2022-06-30) — Basic EPS: -0.03
ICU.AX cash_flow (annual, 2022-06-30) — Beginning Cash Position: 197230.00
ICU.AX balance_sheet (annual, 2022-06-30) — Capital Stock: 30147566.00
ICU.AX balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 69053.00
ICU.AX balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Federal Funds Sold: 69053.00
ICU.AX balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 69053.00
ICU.AX balance_sheet (annual, 2022-06-30) — Cash Financial: 69053.00
ICU.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: 395454.00
ICU.AX cash_flow (annual, 2022-06-30) — Cash Flowsfromusedin Operating Activities Direct: -523631.00
ICU.AX cash_flow (annual, 2022-06-30) — Changes In Cash: -128177.00
ICU.AX cash_flow (annual, 2022-06-30) — Classesof Cash Payments: -3705467.00
ICU.AX cash_flow (annual, 2022-06-30) — Classesof Cash Receiptsfrom Operating Activities: 3181836.00
ICU.AX balance_sheet (annual, 2022-06-30) — Common Stock: 30147566.00
ICU.AX balance_sheet (annual, 2022-06-30) — Common Stock Equity: -3061705.00
ICU.AX balance_sheet (annual, 2022-06-30) — Current Debt: 2498117.00
ICU.AX balance_sheet (annual, 2022-06-30) — Current Debt And Capital Lease Obligation: 2498117.00
ICU.AX balance_sheet (annual, 2022-06-30) — Current Provisions: 66731.00
ICU.AX income_statement (annual, 2022-06-30) — Depreciation Amortization Depletion Income Statement: 158828.00
ICU.AX income_statement (annual, 2022-06-30) — Depreciation And Amortization In Income Statement: 158828.00
ICU.AX income_statement (annual, 2022-06-30) — Depreciation Income Statement: 158828.00
ICU.AX income_statement (annual, 2022-06-30) — Diluted Average Shares: 115431405.00
ICU.AX income_statement (annual, 2022-06-30) — Diluted EPS: -0.03
ICU.AX income_statement (annual, 2022-06-30) — EBIT: -3023910.00
ICU.AX income_statement (annual, 2022-06-30) — EBITDA: -2865082.00
ICU.AX cash_flow (annual, 2022-06-30) — End Cash Position: 69053.00
ICU.AX cash_flow (annual, 2022-06-30) — Financing Cash Flow: 395454.00
ICU.AX cash_flow (annual, 2022-06-30) — Free Cash Flow: -523631.00
ICU.AX income_statement (annual, 2022-06-30) — General And Administrative Expense: 1348781.00
ICU.AX balance_sheet (annual, 2022-06-30) — Gross Accounts Receivable: 122088.00
ICU.AX income_statement (annual, 2022-06-30) — Impairment Of Capital Assets: 8100.00
ICU.AX income_statement (annual, 2022-06-30) — Interest Expense: 86854.00
ICU.AX income_statement (annual, 2022-06-30) — Interest Income: 167.00
ICU.AX balance_sheet (annual, 2022-06-30) — Invested Capital: -563588.00
ICU.AX cash_flow (annual, 2022-06-30) — Issuance Of Debt: 400000.00
ICU.AX cash_flow (annual, 2022-06-30) — Long Term Debt Issuance: 400000.00
ICU.AX cash_flow (annual, 2022-06-30) — Long Term Debt Payments: -4546.00
ICU.AX balance_sheet (annual, 2022-06-30) — Long Term Equity Investment: 100000.00
ICU.AX balance_sheet (annual, 2022-06-30) — Net Debt: 2429064.00
ICU.AX income_statement (annual, 2022-06-30) — Net Income: -3110764.00
ICU.AX income_statement (annual, 2022-06-30) — Net Income Common Stockholders: -3110764.00
ICU.AX income_statement (annual, 2022-06-30) — Net Income Continuous Operations: -3110764.00
ICU.AX income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: -3110764.00
ICU.AX income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: -3110764.00
ICU.AX income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: -3110764.00
ICU.AX income_statement (annual, 2022-06-30) — Net Interest Income: -86687.00
ICU.AX cash_flow (annual, 2022-06-30) — Net Issuance Payments Of Debt: 395454.00
ICU.AX cash_flow (annual, 2022-06-30) — Net Long Term Debt Issuance: 395454.00
ICU.AX balance_sheet (annual, 2022-06-30) — Net Tangible Assets: -3061705.00
ICU.AX income_statement (annual, 2022-06-30) — Normalized EBITDA: -2856982.00
ICU.AX income_statement (annual, 2022-06-30) — Normalized Income: -3102664.00
ICU.AX income_statement (annual, 2022-06-30) — Operating Revenue: -1225554.00
ICU.AX balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 181436167.00
ICU.AX cash_flow (annual, 2022-06-30) — Other Cash Paymentsfrom Operating Activities: 161074.00
ICU.AX balance_sheet (annual, 2022-06-30) — Other Current Borrowings: 2498117.00
ICU.AX income_statement (annual, 2022-06-30) — Other Gand A: 936709.00
ICU.AX income_statement (annual, 2022-06-30) — Other Non Interest Expense: 22450.00
ICU.AX income_statement (annual, 2022-06-30) — Other Non Operating Income Expenses: 190917.00
ICU.AX balance_sheet (annual, 2022-06-30) — Payables: 630089.00
ICU.AX balance_sheet (annual, 2022-06-30) — Payables And Accrued Expenses: 630089.00
ICU.AX income_statement (annual, 2022-06-30) — Pretax Income: -3110764.00
ICU.AX income_statement (annual, 2022-06-30) — Professional Expense And Contract Services Expense: 460968.00
ICU.AX balance_sheet (annual, 2022-06-30) — Receivables: 45088.00
ICU.AX income_statement (annual, 2022-06-30) — Reconciled Depreciation: 158828.00
ICU.AX cash_flow (annual, 2022-06-30) — Repayment Of Debt: -4546.00
ICU.AX balance_sheet (annual, 2022-06-30) — Retained Earnings: -33209271.00
ICU.AX income_statement (annual, 2022-06-30) — Salaries And Wages: 412072.00
ICU.AX income_statement (annual, 2022-06-30) — Selling General And Administration: 1348781.00
ICU.AX balance_sheet (annual, 2022-06-30) — Share Issued: 181436167.00
ICU.AX income_statement (annual, 2022-06-30) — Special Income Charges: -8100.00
ICU.AX balance_sheet (annual, 2022-06-30) — Stockholders Equity: -3061705.00
ICU.AX balance_sheet (annual, 2022-06-30) — Tangible Book Value: -3061705.00
ICU.AX income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: 0.00
ICU.AX income_statement (annual, 2022-06-30) — Tax Provision: 0.00
ICU.AX income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.00
ICU.AX balance_sheet (annual, 2022-06-30) — Total Assets: 237439.00
ICU.AX balance_sheet (annual, 2022-06-30) — Total Capitalization: -3061705.00
ICU.AX balance_sheet (annual, 2022-06-30) — Total Debt: 2498117.00
ICU.AX balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: -3061705.00
ICU.AX balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 3299144.00
ICU.AX income_statement (annual, 2022-06-30) — Total Unusual Items: -8100.00
ICU.AX income_statement (annual, 2022-06-30) — Total Unusual Items Excluding Goodwill: -8100.00
ICU.AX income_statement (annual, 2023-06-30) — +Total Revenue: 15792.00
ICU.AX balance_sheet (annual, 2023-06-30) — Accounts Payable: 447809.00
ICU.AX balance_sheet (annual, 2023-06-30) — Accounts Receivable: 3850.00
ICU.AX balance_sheet (annual, 2023-06-30) — Allowance For Doubtful Accounts Receivable: -83600.00
ICU.AX income_statement (annual, 2023-06-30) — Basic Average Shares: 188407183.00
ICU.AX income_statement (annual, 2023-06-30) — Basic EPS: -0.01
ICU.AX cash_flow (annual, 2023-06-30) — Beginning Cash Position: 69053.00
ICU.AX balance_sheet (annual, 2023-06-30) — Capital Stock: 32733701.00
ICU.AX balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 89965.00
ICU.AX balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Federal Funds Sold: 89965.00
ICU.AX balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Short Term Investments: 89965.00
ICU.AX balance_sheet (annual, 2023-06-30) — Cash Financial: 89965.00
ICU.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Financing Activities: 736029.00
ICU.AX cash_flow (annual, 2023-06-30) — Cash Flowsfromusedin Operating Activities Direct: -715117.00
ICU.AX cash_flow (annual, 2023-06-30) — Changes In Cash: 20912.00
ICU.AX cash_flow (annual, 2023-06-30) — Classesof Cash Payments: -1985522.00
ICU.AX cash_flow (annual, 2023-06-30) — Classesof Cash Receiptsfrom Operating Activities: 1270405.00
ICU.AX balance_sheet (annual, 2023-06-30) — Common Stock: 32733701.00
ICU.AX balance_sheet (annual, 2023-06-30) — Common Stock Equity: -1798805.00
ICU.AX cash_flow (annual, 2023-06-30) — Common Stock Issuance: 83223.00
ICU.AX balance_sheet (annual, 2023-06-30) — Current Debt: 1169780.00
ICU.AX balance_sheet (annual, 2023-06-30) — Current Debt And Capital Lease Obligation: 1169780.00
ICU.AX balance_sheet (annual, 2023-06-30) — Current Provisions: 205000.00
ICU.AX income_statement (annual, 2023-06-30) — Diluted Average Shares: 188407183.00
ICU.AX income_statement (annual, 2023-06-30) — Diluted EPS: -0.01
ICU.AX income_statement (annual, 2023-06-30) — EBIT: -1328095.00
ICU.AX income_statement (annual, 2023-06-30) — EBITDA: -1328095.00
ICU.AX balance_sheet (annual, 2023-06-30) — Employee Benefits: 13092.00
ICU.AX cash_flow (annual, 2023-06-30) — End Cash Position: 89965.00
ICU.AX cash_flow (annual, 2023-06-30) — Financing Cash Flow: 736029.00
ICU.AX cash_flow (annual, 2023-06-30) — Free Cash Flow: -715117.00
ICU.AX balance_sheet (annual, 2023-06-30) — Gains Losses Not Affecting Retained Earnings: 83223.00
ICU.AX income_statement (annual, 2023-06-30) — General And Administrative Expense: 1060941.00
ICU.AX balance_sheet (annual, 2023-06-30) — Gross Accounts Receivable: 87450.00
ICU.AX income_statement (annual, 2023-06-30) — Interest Expense: 78363.00
ICU.AX income_statement (annual, 2023-06-30) — Interest Income: 574.00
ICU.AX balance_sheet (annual, 2023-06-30) — Invested Capital: -629025.00
ICU.AX cash_flow (annual, 2023-06-30) — Issuance Of Capital Stock: 83223.00
ICU.AX cash_flow (annual, 2023-06-30) — Issuance Of Debt: 652806.00
ICU.AX cash_flow (annual, 2023-06-30) — Long Term Debt Issuance: 652806.00
ICU.AX balance_sheet (annual, 2023-06-30) — Long Term Equity Investment: 50000.00
ICU.AX cash_flow (annual, 2023-06-30) — Net Common Stock Issuance: 83223.00
ICU.AX balance_sheet (annual, 2023-06-30) — Net Debt: 1079815.00
ICU.AX income_statement (annual, 2023-06-30) — Net Income: -1406458.00
ICU.AX income_statement (annual, 2023-06-30) — Net Income Common Stockholders: -1406458.00
ICU.AX income_statement (annual, 2023-06-30) — Net Income Continuous Operations: -1406458.00
ICU.AX income_statement (annual, 2023-06-30) — Net Income From Continuing And Discontinued Operation: -1406458.00
ICU.AX income_statement (annual, 2023-06-30) — Net Income From Continuing Operation Net Minority Interest: -1406458.00
ICU.AX income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: -1406458.00
ICU.AX income_statement (annual, 2023-06-30) — Net Interest Income: -77789.00
ICU.AX cash_flow (annual, 2023-06-30) — Net Issuance Payments Of Debt: 652806.00
ICU.AX cash_flow (annual, 2023-06-30) — Net Long Term Debt Issuance: 652806.00
ICU.AX balance_sheet (annual, 2023-06-30) — Net Tangible Assets: -1798805.00
ICU.AX balance_sheet (annual, 2023-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 13092.00
ICU.AX income_statement (annual, 2023-06-30) — Normalized EBITDA: -1328095.00
ICU.AX income_statement (annual, 2023-06-30) — Normalized Income: -1406458.00
ICU.AX income_statement (annual, 2023-06-30) — Operating Revenue: 15792.00
ICU.AX balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 286585881.00
ICU.AX cash_flow (annual, 2023-06-30) — Other Cash Paymentsfrom Operating Activities: 574.00
ICU.AX balance_sheet (annual, 2023-06-30) — Other Current Borrowings: 1169780.00
ICU.AX balance_sheet (annual, 2023-06-30) — Other Equity Adjustments: 83223.00
ICU.AX income_statement (annual, 2023-06-30) — Other Gand A: 731445.00
ICU.AX income_statement (annual, 2023-06-30) — Other Non Interest Expense: 28800.00
ICU.AX income_statement (annual, 2023-06-30) — Other Non Operating Income Expenses: -96045.00
ICU.AX balance_sheet (annual, 2023-06-30) — Other Payable: 128456.00
ICU.AX balance_sheet (annual, 2023-06-30) — Other Receivables: 58296.00
ICU.AX balance_sheet (annual, 2023-06-30) — Payables: 576265.00
ICU.AX balance_sheet (annual, 2023-06-30) — Payables And Accrued Expenses: 576265.00
ICU.AX income_statement (annual, 2023-06-30) — Pretax Income: -1406458.00
ICU.AX income_statement (annual, 2023-06-30) — Professional Expense And Contract Services Expense: 229865.00
ICU.AX balance_sheet (annual, 2023-06-30) — Receivables: 62146.00
ICU.AX balance_sheet (annual, 2023-06-30) — Retained Earnings: -34615729.00
ICU.AX income_statement (annual, 2023-06-30) — Salaries And Wages: 329496.00
ICU.AX income_statement (annual, 2023-06-30) — Selling General And Administration: 1060941.00
ICU.AX balance_sheet (annual, 2023-06-30) — Share Issued: 286585881.00
ICU.AX balance_sheet (annual, 2023-06-30) — Stockholders Equity: -1798805.00
ICU.AX balance_sheet (annual, 2023-06-30) — Tangible Book Value: -1798805.00
ICU.AX income_statement (annual, 2023-06-30) — Tax Effect Of Unusual Items: 0.00
ICU.AX income_statement (annual, 2023-06-30) — Tax Provision: 0.00
ICU.AX income_statement (annual, 2023-06-30) — Tax Rate For Calcs: 0.00
ICU.AX balance_sheet (annual, 2023-06-30) — Total Assets: 202111.00
ICU.AX balance_sheet (annual, 2023-06-30) — Total Capitalization: -1798805.00
ICU.AX balance_sheet (annual, 2023-06-30) — Total Debt: 1169780.00
ICU.AX balance_sheet (annual, 2023-06-30) — Total Equity Gross Minority Interest: -1798805.00
ICU.AX balance_sheet (annual, 2023-06-30) — Total Liabilities Net Minority Interest: 2000916.00
ICU.AX income_statement (annual, 2024-06-30) — +Total Revenue: -992637.00
ICU.AX balance_sheet (annual, 2024-06-30) — Accounts Payable: 277044.00
ICU.AX balance_sheet (annual, 2024-06-30) — Accounts Receivable: 22379.00
ICU.AX balance_sheet (annual, 2024-06-30) — Allowance For Doubtful Accounts Receivable: -24200.00
ICU.AX income_statement (annual, 2024-06-30) — Basic Average Shares: 304511335.00
ICU.AX income_statement (annual, 2024-06-30) — Basic EPS: -0.01
ICU.AX cash_flow (annual, 2024-06-30) — Beginning Cash Position: 89965.00
ICU.AX balance_sheet (annual, 2024-06-30) — Capital Stock: 34009819.00
ICU.AX balance_sheet (annual, 2024-06-30) — Cash And Cash Equivalents: 64439.00
ICU.AX balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Federal Funds Sold: 64439.00
ICU.AX balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Short Term Investments: 292837.00
ICU.AX balance_sheet (annual, 2024-06-30) — Cash Financial: 64439.00
ICU.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Financing Activities: 973770.00
ICU.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Investing Activities: -199462.00
ICU.AX cash_flow (annual, 2024-06-30) — Cash Flowsfromusedin Operating Activities Direct: -799834.00
ICU.AX cash_flow (annual, 2024-06-30) — Changes In Cash: -25526.00
ICU.AX cash_flow (annual, 2024-06-30) — Classesof Cash Payments: -1223413.00
ICU.AX cash_flow (annual, 2024-06-30) — Classesof Cash Receiptsfrom Operating Activities: 423579.00
ICU.AX balance_sheet (annual, 2024-06-30) — Common Stock: 34009819.00
ICU.AX balance_sheet (annual, 2024-06-30) — Common Stock Equity: -2313091.00
ICU.AX balance_sheet (annual, 2024-06-30) — Current Debt: 2306567.00
ICU.AX balance_sheet (annual, 2024-06-30) — Current Debt And Capital Lease Obligation: 2306567.00
ICU.AX income_statement (annual, 2024-06-30) — Depreciation Amortization Depletion Income Statement: 8469.00
ICU.AX income_statement (annual, 2024-06-30) — Depreciation And Amortization In Income Statement: 8469.00
ICU.AX income_statement (annual, 2024-06-30) — Depreciation Income Statement: 8469.00